RankingsPricing
  1. JP-listed companies
  2. Chiome Bioscience Inc.
  3. Financials
  4. Total liabilities

Chiome Bioscience Inc.JP:4583

Market cap
¥7.5B
P/E ratio
SummaryFinancialsHistoryOwnershipWorkforce
Period EndTotal liabilities (Million JPY)YoY (%)
Dec 31, 2024549-7.61%
Dec 31, 2023594+39.79%
Dec 31, 2022425-4.85%
Dec 31, 2021446+16.07%
Dec 31, 2020385+106.12%
Dec 31, 2019187+20.78%
Dec 31, 2018154-23.49%
Dec 31, 2017202-9.90%
Dec 31, 2016224-36.80%
Dec 31, 2015355+19.63%
Dec 31, 2014296

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)